Journal
CLINICAL CASE REPORTS
Volume 7, Issue 5, Pages 888-892Publisher
WILEY
DOI: 10.1002/ccr3.2106
Keywords
argatroban; dabigatran; hematology; hypercoagulability; lung adenocarcinoma; respiratory
Categories
Funding
- Mitsubishi Tanabe Pharma
Ask authors/readers for more resources
Key Clinical Message We report a case of lung adenocarcinoma-associated hypercoagulability leading to venous limb gangrene, managed successfully with argatroban and then dabigatran. Use of idarucizumab permitted diagnostic investigations, leading to targeted antineoplastic therapy with crizotinib, surgical resection with curative intent, and continued survival over 2 years after the index event.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available